US Stocks
ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals Inc (ORIC)


  • $







Key Stats

Today Low/High$11.8 / $12.47
52 Week Low/High$11.28 / $37.89
Market Cap$504.09M

Company Details

ORIC Pharmaceuticalsis a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's lead product candidate, ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. ORIC-101 is currently in two separate Phase 1b trials in combination with (1) Abraxane (nab-paclitaxel) in advanced or metastatic solid tumors and (2) Xtandi (enzalutamide) in metastatic prostate cancer. ORIC's other product candidates include (1) ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens, (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (3) ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers. Beyond these four product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California.
OrganisationORIC Pharmaceuticals Inc
HeadquatersSouth San Francisco, California, US
IndustryHealth Technology
CEOJacob Chacko

Discover more

Frequently Asked Questions

What is ORIC Pharmaceuticals Inc (ORIC) share price today?

Can Indians buy ORIC Pharmaceuticals Inc (ORIC) shares?

How can I buy ORIC Pharmaceuticals Inc (ORIC) shares from India?

Can Fractional shares of ORIC Pharmaceuticals Inc (ORIC) be purchased?

What are the documents required to start investing in ORIC Pharmaceuticals Inc (ORIC) stocks?